Online Database of Chemicals from Around the World Search | Submit | Advertising

chemBlink >> Chemical Listing >> D-Methamphetamine>> Market Analysis Reports
 




Market Analysis Reports of D-Methamphetamine

Methadone (CAS 76-99-3) Market Research Report 2017
... under the name Methadose in the United States. Methadone market is covered in the study Methadone (CAS 76-99-3) Market Research Report 2017. The report encompasses proper description ... summarizes patents in the sphere. It overlooks methadone market situation, names manufacturers, suppliers as well as users. The report also provides current methadone prices in the market.

Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review
... operations and business divisions. Corporate strategy – Analyst’s summarization of the company’s business strategy. SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. Company history – Progression of key events associated with the company. Major products ...

Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

American Bio Medica Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

Avitar Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

CDex, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

Hythiam Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

IDenta Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

LifePoint, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

OraSure Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

PharmChem Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

Psychemedics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

WayPoint Biomedical Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

We&Win Diversification Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Nov, 2017

Addiction - Pipeline Review, H2 2015
... Addiction - Pipeline Review, H2 2015’, provides an overview of the Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Addiction, complete with comparative analysis at various stages, therapeutics assessment ...

National Institute on Drug Abuse - Pharmaceuticals & Healthcare - Deals and Alliances Profile
... Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and ... deals and value reported by the company by year, for a five year period. Deals by Type - Chart and table depicting information including the ...

Substance (Drug) Abuse - Pipeline Review, H2 2015
... Substance (Drug) Abuse - Pipeline Review, H2 2015’, provides an overview of the Substance (Drug) Abuse’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Substance (Drug) Abuse, complete with comparative analysis at various stages, therapeutics assessment ...

Drug Addiction - Pipeline Review, H2 2017
... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

Drug Addiction - Pipeline Review, H1 2017
... pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Drug Addiction (Central Nervous System), complete with analysis by stage of development, drug ...

Substance (Drug) Abuse - Pipeline Review, H1 2015
... Substance (Drug) Abuse - Pipeline Review, H1 2015’, provides an overview of the Substance (Drug) Abuse’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Substance (Drug) Abuse, complete with comparative analysis at various stages, therapeutics assessment ...

Addiction - Pipeline Review, H1 2015
... Addiction - Pipeline Review, H1 2015’, provides an overview of the Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Addiction, complete with comparative analysis at various stages, therapeutics assessment ...

(S)-(+)-Deoxyephedrine (CAS 537-46-2) Market Research Report 2017
Nov, 2017

Global Market Report of (+/-)-METHAMPHETAMINE-D5 (CAS 60124-88-1)
Nov, 2016

Global Market Report of (+/-)-METHAMPHETAMINE (CAS 4846-07-5)
Nov, 2016

Global Market Report of (+/-)-METHAMPHETAMINE-D11 (CAS 152477-88-8)
Nov, 2016

Global Market Report of (+/-)-METHAMPHETAMINE-D8 (CAS 136765-40-7)
Nov, 2016

Global Market Report of (+)METHAMPHETAMINE HYDROCHLORIDE (CAS 51-57-0)
Nov, 2016

Global Market Report of D-METHAMPHETAMINE (CAS 537-46-2)
Nov, 2016

Global Market Report of (+)METHAMPHETAMINE HYDROCHLORIDE (CAS 51-57-0)
Nov, 2016

Global Market Report of D-METHAMPHETAMINE (CAS 537-46-2)
Nov, 2016

BioMedomics, Inc - Product Pipeline Analysis, 2016 Update
... trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to buy Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development ...

methamphetamine Chemical Report
Jan, 2015

methamphetamine hydrochloride Chemical Report
Jan, 2015

(S)-Methylenedioxymethamphetamine Chemical Report
Jan, 2015

Roche Diagnostics International Ltd - Product Pipeline Analysis, 2017 Update
... pipeline products in development for the company Roche Diagnostics International Ltd The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The report covers detailed information on each pipeline product ...

InterveXion Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

2016 Methamphetamine (CAS 537-46-2) Industry Market Report
... -2016 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Methamphetamine ... competitive landscape analysis. The report then estimates 2016-2021 market development trends of Methamphetamine industry. Analysis of upstream raw materials, downstream demand ...

Roche Diagnostics International Ltd. - Product Pipeline Analysis, 2016 Update
... pipeline products in development for the company Roche Diagnostics International Ltd. The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The report covers detailed information on each pipeline product ...

The U.S. Addiction Rehab Industry
Drug, alcohol and other addiction rehab in the United States is big business - $35 billion this year. There ... examines the nature of the business, types of rehab, reasons for the renewed growth of addiction rehab services since the Great Recession, national receipts ...

Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1) - Pipeline Review, H1 2016
... Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1) The report reviews Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1) targeted therapeutics under development ...

Global and Chinese Methamphetamine HCl (CAS 51-57-0) Industry, 2017 Market Research Report
The 'Global and Chinese Methamphetamine HCl Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Methamphetamine HCl industry with a focus on the Chinese ...

(S)-Methylenedioxymethamphetamine CAS Number 66142-89-0 Global Chemical Report
Jul, 2016

Global Methamphetamine Market Research Report 2021
... Methamphetamine in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market ... Merz Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Methamphetamine in these ...

Global Methamphetamine Sales Market Report 2021
... Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Methamphetamine ... III Split by applications, this report focuses on sales, market share and growth rate of Methamphetamine in each application, can be divided into ...

United States Methamphetamine Sales Market Report 2021
... United Pharmacies chemBlink Pink Lotus Skin Clinic MSN Warehouse TSSC Casa Tania Merz Split by product types, with sales, revenue, price, market ... II Type III Split by applications, this report focuses on sales, market share and growth rate of Methamphetamine in each application, can be divided into Medical care ...

Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) - Pipeline Review, H2 2017
... molecule type. It also reviews key players involved in Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) targeted therapeutics development with respective active and ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels of inattention, impulsivity, and hyperactivity, either alone ... , work, home, and in relationships. The majority of children with the disorder will continue to experience symptoms into adolescence. 30-50% of children diagnosed with ...

Global Methamphetamine Market Research Report 2017
... Notes: Production, means the output of Methamphetamine Revenue, means the sales value of Methamphetamine This report studies Methamphetamine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with ...

Global Methamphetamine Sales Market Report 2017
... Sales, means the sales volume of Methamphetamine Revenue, means the sales value of Methamphetamine This report studies sales (consumption) of Methamphetamine in Global market ... by applications, this report focuses on sales, market share and growth rate of Methamphetamine in each application, can be divided into ...

United States Methamphetamine Market Report 2017
... , means the sales volume of Methamphetamine Revenue, means the sales value of Methamphetamine This report studies sales (consumption) of Methamphetamine in United States market, focuses on the top players, with sales, price, revenue and market share for ...








Copyright ©  chemBlink. All rights reserved. Content Disclaimer | About chemBlink | Contact